Skip to content
★ Sign in to follow
DP
Total declarations
169
Companies
2
▲ Purchases (10 ops.)
€926k
▼ Sales (44 ops.)
€56.8M

Latest filing published 15 Nov 2023 for CHEMED CORP, €650k.

Filing timeline

BuySale
David Patrick Williams

Insider track record

Disclosed buys
10
Disclosed sells
44
Signal history

Closed purchases

Market purchases
10
Positive at T+90
60%
Median T+90
+8.3%

Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 12 Feb 2018 · 3191 days ago · €63k
    +13.4%
    Entry US$326.00 · Close at T+365 US$369.80
  • Filed 10 May 2017 · 3469 days ago · €88k
    +69.6%
    Entry US$188.20 · Close at T+365 US$319.20
  • Filed 03 Sept 2015 · 4084 days ago · €48k
    +10.3%
    Entry US$237.20 · Close at T+365 US$261.60
  • Filed 04 Feb 2015 · 4295 days ago · €67k
    -18.8%
    Entry US$336.80 · Close at T+365 US$273.60
  • Filed 03 Sept 2014 · 4449 days ago · €57k
    -29.7%
    Entry US$337.60 · Close at T+365 US$237.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

David Patrick Williams: trading record in brief

David Patrick Williams discloses dealings in 2 companies, chiefly Chemed Corp and Regis Corp. Over a trading history stretching from 9 February 2006 to 14 November 2023, the count stands at 169 filings.

Market trades split into 10 purchases (€926k) and 44 sales (€56.8M). The net balance comes to €55.9M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 71 share grants and 41 option exercises. Since January 2023: no purchases and 6 sales on the market.

The median purchase comes to €65k. After 10 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +8.3%. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 15 November 2023: an open-market sale of €650k, in Chemed Corp. The last insider purchase was made public on 12 February 2018, 3,191 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to David Patrick Williams

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations166 total
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    695,091 USD34SEC
    1,186 shares@ US$586.080.4% of flowcapital stockSEC:0001209191-23-055282:1
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    2M USD32SEC
    3,814 shares@ US$586.325.5% of flowcapital stockSEC:0001209191-23-055282:0
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    3M USD32SEC
    5,000 shares@ US$580.797.2% of flowcapital stockSEC:0001209191-23-054945:0
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    4M USD32SEC
    6,000 shares@ US$583.858.6% of flowcapital stockSEC:0001209191-23-054668:0
  • ◇
    Executive vice president & CFOExecutivesChemed Corp
    6M USD19SEC
    12,396 shares@ US$445.353.1% of flowcapital stockSEC:0001209191-23-054481:1
  • ◇
    Executive vice president & CFOExecutivesChemed Corp
    3M USD19SEC
    6,024 shares@ US$462.041.6% of flowcapital stockSEC:0001209191-23-054481:2
  • ◆
    Executive vice president & CFOExecutivesChemed Corp
    18M USD20SEC
    31,141 shares@ US$578.3910.1% of flowcapital stockSEC:0001209191-23-054481:3
  • ◇
    Executive vice president & CFOExecutivesChemed Corp
    8M USD21SEC
    16,815 shares@ US$471.7419.8% of flowcapital stockSEC:0001209191-23-054481:0
  • ◇
    Executive vice president & CFOExecutivesChemed Corp
    6M USD19SEC
    15,100 shares@ US$413.193.5% of flowcapital stockSEC:0001209191-23-054111:1
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    3M USD31SEC
    5,000 shares@ US$568.871.6% of flowcapital stockSEC:0001209191-23-054111:2
  • ◆
    Executive vice president & CFOExecutivesChemed Corp
    7M USD21SEC
    12,811 shares@ US$562.3217.9% of flowcapital stockSEC:0001209191-23-054111:0
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    2M USD32SEC
    4,000 shares@ US$523.255.2% of flowcapital stockSEC:0001209191-23-020178:0
  • ◇
    Executive vice president & CFOExecutivesChemed Corp
    304,951 USD19SEC
    592 shares@ US$515.120.2% of flowcapital stockSEC:0001209191-23-011539:1
  • ◆
    Executive vice president & CFOExecutivesChemed Corp
    367,796 USD19SEC
    714 shares@ US$515.120.2% of flowcapital stockSEC:0001209191-23-011539:2
  • ◇
    Executive vice president & CFOExecutivesChemed Corp
    535,725 USD19SEC
    1,040 shares@ US$515.121.3% of flowcapital stockSEC:0001209191-23-011539:0
  • ◇
    Executive vice president & CFOExecutivesChemed Corp
    5M USD19SEC
    15,500 shares@ US$306.702.7% of flowcapital stockSEC:0001209191-22-056548:1
  • ◆
    Executive vice president & CFOExecutivesChemed Corp
    6M USD19SEC
    12,135 shares@ US$494.553.5% of flowcapital stockSEC:0001209191-22-056548:2
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    4M USD38SEC
    8,000 shares@ US$497.3110.5% of flowcapital stockSEC:0001209191-22-056548:0
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    245,500 USD37SEC
    500 shares@ US$491.000.1% of flowcapital stockSEC:0001209191-22-056348:1
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    493,000 USD37SEC
    1,000 shares@ US$493.001.3% of flowcapital stockSEC:0001209191-22-056348:0
  • ◆
    Executive vice president & CFOExecutivesChemed Corp
    7M USD19SEC
    13,196 shares@ US$502.053.8% of flowcapital stockSEC:0001209191-22-029104:1
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    6M USD34SEC
    12,000 shares@ US$500.853.5% of flowcapital stockSEC:0001209191-22-029104:2
  • ◇
    Executive vice president & CFOExecutivesChemed Corp
    3M USD20SEC
    24,000 shares@ US$106.596.5% of flowcapital stockSEC:0001209191-22-029104:0
  • ◆
    Executive vice president & CFOExecutivesChemed Corp
    7M USD19SEC
    13,873 shares@ US$499.833.9% of flowcapital stockSEC:0001209191-22-027510:1
  • ▼
    Executive vice president & CFOExecutivesChemed Corp
    2M USD34SEC
    4,000 shares@ US$500.381.1% of flowcapital stockSEC:0001209191-22-027510:2

25 of 166 declarations